Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells

Chuen Mao Yang, Yih Jeng Tsai, Shiow Lin Pan, Wen Bin Wu, Chuan Chwan Wang, Ying Shiung Lee, Chih Chung Lin, Samuel C M Huang, Chi Tso Chiu

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The pharmacological properties of bradykinin receptors were characterized in rat cultured vascular smooth muscle cells (VSMCs) using [3H]-bradykinin as a ligand. Analysis of binding isotherms gave an apparent equilibrium dissociation constant (K(D)) of 1.2 ± 0.2 nM and a maximum receptor density (B(max)) of 47.3 ± 4.4 fmol/mg protein. The specific binding of [3H]-bradykinin to VSMCs was inhibited by the B2 receptor-selective agonists (bradykinin and kallidin) and antagonists ([D-Arg0, Hyp3, Thi5, D-Tic7, Oic8]-bradykinin (Hoe 140) and [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) with an order of potency as kallidin = bradykinin = Hoe 140 > [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin, but not by a B1 receptor-selective agonist (des-Arg9-bradykinin) and antagonist ([Leu8, des-Arg9]-bradykinin). Stimulation of VSMCs by bradykinin produced a concentration-dependent inositol phosphate (IP) accumulation, and initial transient peak of [Ca2+](i) with half-maximal responses (pEC50) were 7.53 and 7.69, respectively. B2 receptor-selective antagonists (Hoe 140 and [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) significantly antagonized the bradykinin-induced responses with pK(B) values of 8.3-8.7 and 7.2-7.9, respectively. Pretreatment of VSMCs with pertussis toxin (100 ng/ml, 24 h) did not alter the bradykinin-induced inositol phosphate accumulation and [Ca2+](i) changes in VSMCs. Removal of external Ca2+ led to a significant attenuation of responses induced by bradykinin. Influx of external Ca2+ was required for the bradykinin-induced responses, since Ca2+-channel blockers, nifedipine, verapamil, and Ni2+, partially inhibited the bradykinin-induced IP accumulation and Ca2+ mobilization. These results demonstrate that bradykinin stimulates phosphoinositide hydrolysis and Ca2+ mobilization via a pertussis toxin-insensitive G-protein in rat VSMCs. Bradykinin B2 receptors may be predominantly mediating IP accumulation and subsequently induction of Ca2+ mobilization may function as the transducing mechanism for bradykinin-stimulated contraction of vascular smooth muscle. Copyright (C) 1999 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)853-862
Number of pages10
JournalCellular Signalling
Volume11
Issue number12
DOIs
Publication statusPublished - Dec 1999
Externally publishedYes

Fingerprint

Bradykinin Receptors
Bradykinin
Vascular Smooth Muscle
Smooth Muscle Myocytes
Pharmacology
Inositol Phosphates
Kallidin
Pertussis Toxin
Bradykinin B2 Receptors

Keywords

  • Bradykinin receptor
  • Ca
  • Inositol phosphate
  • Pertussis toxin
  • Vascular smooth muscle cells

ASJC Scopus subject areas

  • Cell Biology

Cite this

Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells. / Yang, Chuen Mao; Tsai, Yih Jeng; Pan, Shiow Lin; Wu, Wen Bin; Wang, Chuan Chwan; Lee, Ying Shiung; Lin, Chih Chung; Huang, Samuel C M; Chiu, Chi Tso.

In: Cellular Signalling, Vol. 11, No. 12, 12.1999, p. 853-862.

Research output: Contribution to journalArticle

Yang, Chuen Mao ; Tsai, Yih Jeng ; Pan, Shiow Lin ; Wu, Wen Bin ; Wang, Chuan Chwan ; Lee, Ying Shiung ; Lin, Chih Chung ; Huang, Samuel C M ; Chiu, Chi Tso. / Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells. In: Cellular Signalling. 1999 ; Vol. 11, No. 12. pp. 853-862.
@article{6fd95e2e487a4bddace363cda80fffc5,
title = "Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells",
abstract = "The pharmacological properties of bradykinin receptors were characterized in rat cultured vascular smooth muscle cells (VSMCs) using [3H]-bradykinin as a ligand. Analysis of binding isotherms gave an apparent equilibrium dissociation constant (K(D)) of 1.2 ± 0.2 nM and a maximum receptor density (B(max)) of 47.3 ± 4.4 fmol/mg protein. The specific binding of [3H]-bradykinin to VSMCs was inhibited by the B2 receptor-selective agonists (bradykinin and kallidin) and antagonists ([D-Arg0, Hyp3, Thi5, D-Tic7, Oic8]-bradykinin (Hoe 140) and [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) with an order of potency as kallidin = bradykinin = Hoe 140 > [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin, but not by a B1 receptor-selective agonist (des-Arg9-bradykinin) and antagonist ([Leu8, des-Arg9]-bradykinin). Stimulation of VSMCs by bradykinin produced a concentration-dependent inositol phosphate (IP) accumulation, and initial transient peak of [Ca2+](i) with half-maximal responses (pEC50) were 7.53 and 7.69, respectively. B2 receptor-selective antagonists (Hoe 140 and [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) significantly antagonized the bradykinin-induced responses with pK(B) values of 8.3-8.7 and 7.2-7.9, respectively. Pretreatment of VSMCs with pertussis toxin (100 ng/ml, 24 h) did not alter the bradykinin-induced inositol phosphate accumulation and [Ca2+](i) changes in VSMCs. Removal of external Ca2+ led to a significant attenuation of responses induced by bradykinin. Influx of external Ca2+ was required for the bradykinin-induced responses, since Ca2+-channel blockers, nifedipine, verapamil, and Ni2+, partially inhibited the bradykinin-induced IP accumulation and Ca2+ mobilization. These results demonstrate that bradykinin stimulates phosphoinositide hydrolysis and Ca2+ mobilization via a pertussis toxin-insensitive G-protein in rat VSMCs. Bradykinin B2 receptors may be predominantly mediating IP accumulation and subsequently induction of Ca2+ mobilization may function as the transducing mechanism for bradykinin-stimulated contraction of vascular smooth muscle. Copyright (C) 1999 Elsevier Science Inc.",
keywords = "Bradykinin receptor, Ca, Inositol phosphate, Pertussis toxin, Vascular smooth muscle cells",
author = "Yang, {Chuen Mao} and Tsai, {Yih Jeng} and Pan, {Shiow Lin} and Wu, {Wen Bin} and Wang, {Chuan Chwan} and Lee, {Ying Shiung} and Lin, {Chih Chung} and Huang, {Samuel C M} and Chiu, {Chi Tso}",
year = "1999",
month = "12",
doi = "10.1016/S0898-6568(99)00056-X",
language = "English",
volume = "11",
pages = "853--862",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells

AU - Yang, Chuen Mao

AU - Tsai, Yih Jeng

AU - Pan, Shiow Lin

AU - Wu, Wen Bin

AU - Wang, Chuan Chwan

AU - Lee, Ying Shiung

AU - Lin, Chih Chung

AU - Huang, Samuel C M

AU - Chiu, Chi Tso

PY - 1999/12

Y1 - 1999/12

N2 - The pharmacological properties of bradykinin receptors were characterized in rat cultured vascular smooth muscle cells (VSMCs) using [3H]-bradykinin as a ligand. Analysis of binding isotherms gave an apparent equilibrium dissociation constant (K(D)) of 1.2 ± 0.2 nM and a maximum receptor density (B(max)) of 47.3 ± 4.4 fmol/mg protein. The specific binding of [3H]-bradykinin to VSMCs was inhibited by the B2 receptor-selective agonists (bradykinin and kallidin) and antagonists ([D-Arg0, Hyp3, Thi5, D-Tic7, Oic8]-bradykinin (Hoe 140) and [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) with an order of potency as kallidin = bradykinin = Hoe 140 > [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin, but not by a B1 receptor-selective agonist (des-Arg9-bradykinin) and antagonist ([Leu8, des-Arg9]-bradykinin). Stimulation of VSMCs by bradykinin produced a concentration-dependent inositol phosphate (IP) accumulation, and initial transient peak of [Ca2+](i) with half-maximal responses (pEC50) were 7.53 and 7.69, respectively. B2 receptor-selective antagonists (Hoe 140 and [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) significantly antagonized the bradykinin-induced responses with pK(B) values of 8.3-8.7 and 7.2-7.9, respectively. Pretreatment of VSMCs with pertussis toxin (100 ng/ml, 24 h) did not alter the bradykinin-induced inositol phosphate accumulation and [Ca2+](i) changes in VSMCs. Removal of external Ca2+ led to a significant attenuation of responses induced by bradykinin. Influx of external Ca2+ was required for the bradykinin-induced responses, since Ca2+-channel blockers, nifedipine, verapamil, and Ni2+, partially inhibited the bradykinin-induced IP accumulation and Ca2+ mobilization. These results demonstrate that bradykinin stimulates phosphoinositide hydrolysis and Ca2+ mobilization via a pertussis toxin-insensitive G-protein in rat VSMCs. Bradykinin B2 receptors may be predominantly mediating IP accumulation and subsequently induction of Ca2+ mobilization may function as the transducing mechanism for bradykinin-stimulated contraction of vascular smooth muscle. Copyright (C) 1999 Elsevier Science Inc.

AB - The pharmacological properties of bradykinin receptors were characterized in rat cultured vascular smooth muscle cells (VSMCs) using [3H]-bradykinin as a ligand. Analysis of binding isotherms gave an apparent equilibrium dissociation constant (K(D)) of 1.2 ± 0.2 nM and a maximum receptor density (B(max)) of 47.3 ± 4.4 fmol/mg protein. The specific binding of [3H]-bradykinin to VSMCs was inhibited by the B2 receptor-selective agonists (bradykinin and kallidin) and antagonists ([D-Arg0, Hyp3, Thi5, D-Tic7, Oic8]-bradykinin (Hoe 140) and [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) with an order of potency as kallidin = bradykinin = Hoe 140 > [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin, but not by a B1 receptor-selective agonist (des-Arg9-bradykinin) and antagonist ([Leu8, des-Arg9]-bradykinin). Stimulation of VSMCs by bradykinin produced a concentration-dependent inositol phosphate (IP) accumulation, and initial transient peak of [Ca2+](i) with half-maximal responses (pEC50) were 7.53 and 7.69, respectively. B2 receptor-selective antagonists (Hoe 140 and [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) significantly antagonized the bradykinin-induced responses with pK(B) values of 8.3-8.7 and 7.2-7.9, respectively. Pretreatment of VSMCs with pertussis toxin (100 ng/ml, 24 h) did not alter the bradykinin-induced inositol phosphate accumulation and [Ca2+](i) changes in VSMCs. Removal of external Ca2+ led to a significant attenuation of responses induced by bradykinin. Influx of external Ca2+ was required for the bradykinin-induced responses, since Ca2+-channel blockers, nifedipine, verapamil, and Ni2+, partially inhibited the bradykinin-induced IP accumulation and Ca2+ mobilization. These results demonstrate that bradykinin stimulates phosphoinositide hydrolysis and Ca2+ mobilization via a pertussis toxin-insensitive G-protein in rat VSMCs. Bradykinin B2 receptors may be predominantly mediating IP accumulation and subsequently induction of Ca2+ mobilization may function as the transducing mechanism for bradykinin-stimulated contraction of vascular smooth muscle. Copyright (C) 1999 Elsevier Science Inc.

KW - Bradykinin receptor

KW - Ca

KW - Inositol phosphate

KW - Pertussis toxin

KW - Vascular smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0032763712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032763712&partnerID=8YFLogxK

U2 - 10.1016/S0898-6568(99)00056-X

DO - 10.1016/S0898-6568(99)00056-X

M3 - Article

VL - 11

SP - 853

EP - 862

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 12

ER -